While several COVID-19 vaccinations have been distributed all around the globe, global health officials are seeking for more candidates in the hopes of expanding the global supply. The latest addition to the vaccine line is Canada’s plant based COVID vaccine.
- EXPLOSIVE: Here’s what was uncovered in Hunter Biden’s iCloud Hack
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
Canada became the first country to approve the usage of a COVID-19 vaccine made from plants, reports Business Insider.
Medicago’s two-dose vaccine can be offered to adults ages 18 to 64, according to Canadian regulators, but there isn’t enough data on the doses in individuals 65 and older.
The conclusion was made based on research of 24,000 adults that revealed the vaccine to be 71% efficient in stopping COVID-19 – but this was before the omicron strain was discovered. Fever and exhaustion were among the minor side effects.
Plants are used by Medicago to create virus-like particles that are similar to the spike protein that wraps the coronavirus. The particles are cleaned after being taken from the leaves of the plants.
Subscribe to GreatGameIndia
The shots also contain an adjuvant, which is an immune-boosting substance produced by GlaxoSmithKline, a British partner.
While several COVID-19 vaccinations have been distributed all around the globe, global health officials are seeking for more candidates in the hopes of expanding the global supply.
Based in Quebec City, Medicago is working on plant-based vaccines for a variety of ailments, and the COVID-19 vaccine could assist to increase interest in this new technique of medical production.